| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58461250aa0b3318913cba131e0a4599
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b0fe3d52e5e1453b710ab5c22bae5a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25e46a7db4845c1de06b26ac39a486aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80998ecad6fa12a3586ec620e1268362
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76575d4776f4df9a03516560f30ebfa5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-811 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-56 |
| filingDate |
2002-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c18999e9b8bcf41ee5c2e977e95888b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76a66494ef3543ee837d61ac1d09e287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e632527197ac78e18b2f82652e8f14ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774c1c96fa6a6ef59363cff51a932b65 |
| publicationDate |
2003-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02070029-A3 |
| titleOfInvention |
Porous beta-tricalcium phosphate granules and methods for producing same |
| abstract |
A porous β-tricalcium phosphate material for bone implantation is provided. The multiple pores in the porous TCP body are separate discrete voids and are not interconnected. The pore size diameter is in the range of 20-500 µm, preferably 50-125 µm. The porous β-TCP material provides a carrier matrix for bioactive agents and can form a moldable putty composition upon the addition of a binder. Preferably, the bioactive agent is encapsulated in a biodegradable agent. The invention provides a kit and an implant device comprising the porous β-TCP, and a bioactive agent and a binder. The invention also provides an implementable prosthetic device comprising a prosthetic implant having a surface region, a porous β-TCP material disposed on the surface region optionally comprising at least a bioactive agent or a binder. Methods of producing the porous β-TCP material and including bone formation are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763270-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8257728-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9545377-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9161967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8870954-B2 |
| priorityDate |
2001-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |